Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

• Κύριοι συγγραφείς: Saowalak Turongkaravee (Συγγραφέας), Jiraphun Jittikoon (Συγγραφέας), Onwipa Rochanathimoke (Συγγραφέας), Kathleen Boyd (Συγγραφέας), Olivia Wu (Συγγραφέας), Usa Chaikledkaew (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2021-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would be useful for clinical practice and policy decision-making on allocatin...